Dow Jones

51 056,38

0,37%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Map Pharmaceuticals, Inc. (MM) (MAPP)
Map Pharmaceuticals, Inc. (MM) (MAPP) Actualités

Map Pharmaceuticals, Inc. (MM) (MAPP)

24,98

0,00

( 0,00% )

Mis à jour : 02:00:00

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT...

Amended Statement of Ownership: Solicitation (sc 14d9/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

(25-NSE)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Amended Statement of Beneficial Ownership (sc 13d/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Allergan, Inc. Announces Expiration of Tender Offer for All Outstanding Shares of MAP Pharmaceuticals, Inc. & Intent to Exerc...

Allergan, Inc. (NYSE: AGN) (“Allergan”) today announced the expiration of the tender offer (the “Offer”) initiated by its wholly-owned...

Amended Statement of Ownership (sc 13g/a)

SCHEDULE 13G Amendment No. 5 MAP PHARMACEUTICALS INC Common Stock Cusip #56509R108 Cusip...

Statement of Ownership (sc 13g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange...

Statement of Ownership (sc 13g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE...

Amended Statement of Ownership (sc 13g/a)

DOCUMENT TYPE SC 13G/A TEXT SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the...

Amended Statement of Ownership (sc 13g/a)

Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of...

Amended Statement of Ownership (sc 13g/a)

SECURITIES AND EXCHANGE COMMISSION Washington...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

FansUnite Entertainment

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

Vous avez déjà un compte? Connexion

Vous n'avez pas de compte ? Inscription

En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Map Pharmaceuticals, Inc. (MM) (MAPP)

Outils de qualité professionnelle, pour des investisseurs individuels.